1.99
6.42%
0.12
After Hours:
1.98
-0.01
-0.50%
Milestone Pharmaceuticals Inc Stock (MIST) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Research and Development |
33.25%
3.639
|
5.452 | 6.721 | 8.622 | 10.26 |
Interest Income/Expense |
1.75%
0.872
|
0.857 | 0.841 | 0.82 | 0.036 |
Operating Income/Loss |
24.09%
-10.48
|
-13.80 | -15.36 | -16.44 | -15.50 |
Income/Loss From Continuing Operations Before Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
Income/Loss From Continuing Operations After Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
Net Income/Loss
|
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
Diluted Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):